Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

UAMS Winthrop P. Rockefeller Cancer Institute receives five NCI grants

Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences have been awarded five grants from NCI in 2024, totaling $4.6 million.

June 28, 2024

Vol.50 No.26

Obituary

“Father of tamoxifen” V. Craig Jordan dies at 76

Pharmacologist V. Craig Jordan, a professor of Breast and Medical Oncology and Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center who discovered selective estrogen receptor modulators and developed breakthrough breast cancer treatments, died June 9 at his home in Houston.

June 14, 2024

Vol.50 No.24

By MD Anderson Cancer Center staff

In the Archives

In an interview and a memoir, V. Craig Jordan spoke about his life and SERMs

V. Craig Jordan, a pharmacologist who discovered selective estrogen receptor modulators, died on June 9. Jordan, a professor at The University of Texas MD Anderson Cancer Center who was credited with discovery of tamoxifen, was 76. An obituary appears in this issue. Jordan appeared on the Cancer History Project podcast in 2022 to discuss...

June 14, 2024

Vol.50 No.24

Clinical Roundup

AI improves physicians’ ability to identify prostate cancer extent

Investigators from UCLA Health found using artificial intelligence to help map out the boundaries of cancerous prostate tissue can significantly reduce the risk of underestimating the extent of prostate cancer—an advancement that can help ensure an accurate diagnosis, precise treatment planning and effective surgical procedures.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Hydroxychloroquine + lapatinib may reduce breast cancer metastases

A study led by researchers from the University of Arizona Cancer Center at UArizona Health Sciences identified a biological mechanism that could lead to more effective treatments for breast cancer that has metastasized to the brain. The work was published in Clinical and Translational Medicine.

June 14, 2024

Vol.50 No.24

In Brief

Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research

Dennis Slamon, an oncologist and scientist whose research has transformed the treatment of breast cancer, was awarded the 2024 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

June 07, 2024

Vol.50 No.23

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

YOU MAY BE INTERESTED IN

UAMS Winthrop P. Rockefeller Cancer Institute receives five NCI grants

“Father of tamoxifen” V. Craig Jordan dies at 76

In an interview and a memoir, V. Craig Jordan spoke about his life and SERMs

AI improves physicians’ ability to identify prostate cancer extent

Hydroxychloroquine + lapatinib may reduce breast cancer metastases

Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research

Renew today!

Subscriber content

Login